NASDAQ : LQDA

Liquidia Corporation — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 44.99 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.03B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap4.03B
Enterprise Value3.93B

Dates

MeasureValue
Earnings DateNov 13, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class89.51M
Shares Outstanding89.51M
Shares Change (YoY)+12.65%
Shares Change (QoQ)+0.28%
Owned by Insiders (%)8.72%
Owned by Institutions (%)64.71%
Float65.21M

Ratios

MeasureValue
PE Ratio30.49
Forward PE42.67
PS Ratio8.94
Forward PS5.12
PB Ratio20.58
P/TBV Ratio21.41
P/FCF Ratio26.76
P/OCF Ratio24.05
PEG Ration/a

Evratios

MeasureValue
EV / Earnings28.37
EV / Sales8.72
EV / EBITDA23.16
EV / EBIT23.32
EV / FCF26.09

Financialposition

MeasureValue
Current Ratio2.31
Quick Ratio2.07
Debt / Equity0.94
Debt / EBITDA1.07
Debt / FCF1.21
Interest Coverage6.33

Financialefficiency

MeasureValue
Return on Equity (ROE)131.82%
Return on Assets (ROA)27.04%
Return on Invested Capital (ROIC)190.08%
Return on Capital Employed (ROCE)50.68%
Weighted Average Cost of Capital (WACC)7.86%
Revenue Per Employee$2.09M
Profits Per Employee$641,694
Employee Count216
Asset Turnover1.16
Inventory Turnover1.58

Taxes

MeasureValue
Income Tax10.90M
Effective Tax Rate7.29%

Stockprice

MeasureValue
Beta (5Y)0.61
52-Week Price Change+100.71%
50-Day Moving Average52.99
200-Day Moving Average54.30
Relative Strength Index (RSI)52.53
Average Volume (20 Days)5,323,516

Shortselling

MeasureValue
Short Interest17.30M
Short Previous Month12.64M
Short % of Shares Out19.33%
Short % of Float26.53%
Short Ratio (days to cover)2.89

Incomestatement

MeasureValue
Revenue450.91M
Gross Profit417.28M
Operating Income168.58M
Pretax Income149.50M
Net Income138.61M
EBITDA169.77M
EBIT168.58M
Earnings Per Share (EPS)$1.48

Balancesheet

MeasureValue
Cash & Cash Equivalents284.18M
Total Debt182.90M
Net Cash101.29M
Net Cash Per Share$1.13
Equity (Book Value)195.11M
Book Value Per Share2.19
Working Capital248.41M

Cashflow

MeasureValue
Operating Cash Flow167.71M
Capital Expenditures-17.01M
Depreciation & Amortization1.19M
Net Borrowing-44.14M
Free Cash Flow150.69M
FCF Per Share$1.68

Margins

MeasureValue
Gross Margin92.54%
Operating Margin37.39%
Pretax Margin33.16%
Profit Margin30.74%
EBITDA Margin37.65%
EBIT Margin37.39%
FCF Margin33.42%

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yield-12.65%
Shareholder Yield-12.65%
Earnings Yield3.28%
FCF Yield3.74%

Analystforecasts

MeasureValue
Price Target$54.38
Price Target Difference20.68%
Analyst ConsensusBuy
Analyst Count8
Revenue Growth Forecast (3Y)74.96%
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score6.79
Piotroski F-Score7

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Number
Graham Upside